Related Topics News -

     
 Detail   |   Print    Next page > 
     
《大行》大華繼顯:行業進入加速增長新階段 首選翰森製藥信達生物中國生物製藥
2025-06-19T  
長江生命科技李澤鉅:買股票純為收息沒理由投資生物科技行業
2025-05-22T  
長江生命科技:將在AACR年會上展示癌症疫苗臨床前研究數據
2025-04-22T  
長江生命科技復牌一度升42% 癌症疫苗於香港及美國交專利申請
2025-04-11T  
《復牌》長江生命科技癌症疫苗於香港及美國交專利申請 今早復牌
2025-04-11T  
長江生命科技今早起停牌 待刊發公告
2025-04-10T  
長江生命科技今早起停牌 暫未披露原因
2025-04-10T  
長江生命科技公眾持股量恢復至逾25%
2025-03-24T  
《業績》長江生命科技全年虧損1.27億元 盈轉虧
2025-03-18T  
《盈警》長江生命科技預告全年轉虧1.27億元
2025-03-07T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.